Abiopharma

Director Monia Brett P 🟡 adjusted position in 203.8K shares (4 derivative) of IONIS PHARMACEUTICALS INC (IONS) at $61.06 ($30.4M) Transaction Date: Sep 03, 2025 | Filing ID: 000221

Director KLEIN JOSEPH III 🟡 adjusted position in 28.0K shares (2 derivative) of IONIS PHARMACEUTICALS INC (IONS) at $60.00 ($3.0M) Transaction Date: Sep 03, 2025 | Filing ID: 000220

Director KLEIN JOSEPH III 🟡 adjusted position in 28.0K shares (2 derivative) of IONIS PHARMACEUTICALS INC (IONS) at $60.00 ($3.0M) Transaction Date: Sep 03, 2025 | Filing ID: 000219

Geary Richard S 🔴 sold 10.0K shares of IONIS PHARMACEUTICALS INC (IONS) at $50.37 Transaction Date: Sep 02, 2025 | Filing ID: 000218

Thompson Christopher Charles 🟢 acquired 45.0K shares (1 derivative) of FRACTYL HEALTH, INC. (GUTS) at $0.98 Transaction Date: Sep 02, 2025 | Filing ID: 113125

Director WENDER JOSEPH H 🔴 sold 28.0K shares of IONIS PHARMACEUTICALS INC (IONS) at $60.14 ($1.6M) Transaction Date: Sep 02, 2025 | Filing ID: 000216

Baroldi Joseph 🟡 adjusted position in 32.8K shares (3 derivative) of IONIS PHARMACEUTICALS INC (IONS) at $62.01 ($4.0M) Transaction Date: Sep 03, 2025 | Filing ID: 000215

O'NEIL PATRICK R. 🟡 adjusted position in 89.9K shares (4 derivative) of IONIS PHARMACEUTICALS INC (IONS) at $61.42 ($13.5M) Transaction Date: Sep 02, 2025 | Filing ID: 000214

Director LOSCALZO JOSEPH 🟡 adjusted position in 16.0K shares (1 derivative) of IONIS PHARMACEUTICALS INC (IONS) at $60.15 ($1.7M) Transaction Date: Sep 03, 2025 | Filing ID: 000212

Schneider Eugene 🟡 adjusted position in 19.7K shares (1 derivative) of IONIS PHARMACEUTICALS INC (IONS) at $61.42 ($3.3M) Transaction Date: Sep 03, 2025 | Filing ID: 000211

New Form 3 - FRACTYL HEALTH, INC. Filed: 2025-09-04 AccNo: 0000950170-25-113121 Size: 24 KB

Morrell Martha 🔴 sold 1.3K shares of NeuroPace Inc (NPCE) at $9.36 Transaction Date: Sep 03, 2025 | Filing ID: 023763

Smithfield Foods Announces Pricing of Upsized Secondary Offering of Common Stock

Sheffield Ian 🟢 acquired 45.0K shares (1 derivative) of FRACTYL HEALTH, INC. (GUTS) at $0.98 Transaction Date: Sep 02, 2025 | Filing ID: 113112

[Press Release] HUTCHMED Highlights Clinical Data to be Presented at the 2025 World Conference of Lung Cancer and the CSCO Annual Meeting 2025